Europe Let Its Antibiotics Drift to China. Sandoz Is Asking Brussels to Fight Back
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Europe let its antibiotics drift to China. Sandoz is asking Brussels to fight back
For most of the past two decades, Europe treated the antibiotic as the most disposable thing in its medicine cabinet: cheap, generic, endlessly available, and therefore not worth making at home. That quiet assumption is now the subject of a formal complaint in Brussels. Offshoring penicillin was never really a decision about chemistry. It was a decision about price. Generic antibiotics carry margins so thin that European producers spent years cl…
Asia’s Low Prices Trigger the Antibiotic Crisis in Europe and Put the Pharmaceutical Supply in Check
I have been reviewing the latest movements in the pharmaceutical supply chain and the alert launched this week by Sandoz deserves a paused reading from the perspective of global value chains. The company, leader in generic and biosimilar medicines, has put its finger on the scourge of strategic vulnerability: Europe is one step away from losing all capacity to produce penicillin antibiotics due to unsustainable pressure from Asian, especially Ch…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
